FDA — authorised 29 December 1989
- Application: NDA019693
- Marketing authorisation holder: LILLY
- Local brand name: DECABID
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
🇺🇸 Decabid in United States
FDA authorised Decabid on 29 December 1989
Marketing authorisations
FDA
- Marketing authorisation holder: LILLY
- Status: approved
Decabid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Decabid approved in United States?
Yes. FDA authorised it on 29 December 1989; FDA has authorised it.
Who is the marketing authorisation holder for Decabid in United States?
LILLY holds the US marketing authorisation.